Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity

[1]  Qinghua Xu,et al.  90-gene signature assay for tissue origin diagnosis of brain metastases , 2019, Journal of Translational Medicine.

[2]  D. Ryan,et al.  Histologic and Outcome Study Supports Reclassifying Appendiceal Goblet Cell Carcinoids as Goblet Cell Adenocarcinomas, and Grading and Staging Similarly to Colonic Adenocarcinomas , 2018, The American journal of surgical pathology.

[3]  Weei‐Yuarn Huang,et al.  Goblet cell carcinoid of the appendix - An interobserver variability study using two proposed classification systems. , 2018, Annals of diagnostic pathology.

[4]  W. Weichert,et al.  Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix , 2018, Modern Pathology.

[5]  S. Kakar,et al.  Appendiceal goblet cell carcinoid: common errors in staging and clinical interpretation with a proposal for an improved terminology. , 2017, Human pathology.

[6]  M. Kloor,et al.  Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas , 2017, Modern Pathology.

[7]  A. Krasinskas,et al.  Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases , 2016, Modern Pathology.

[8]  Lin Yuan,et al.  Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin , 2016, Modern Pathology.

[9]  W. Frankel,et al.  Mixed Adeno-neuroendocrine Carcinoma: An Aggressive Clinical Entity , 2016, Annals of Surgical Oncology.

[10]  H. Kennecke,et al.  Simplified 2-tier histologic grading system accurately predicts outcomes in goblet cell carcinoid of the appendix. , 2015, Human pathology.

[11]  A. Rashid,et al.  Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis. , 2015, Archives of pathology & laboratory medicine.

[12]  A. Ginori,et al.  Amphicrine Carcinoma of the Ampullary Region , 2015, Tumori.

[13]  M. Fassan,et al.  Mixed Adenoneuroendocrine Carcinomas of the Gastrointestinal Tract: Targeted Next-Generation Sequencing Suggests a Monoclonal Origin of the Two Components , 2014, Neuroendocrinology.

[14]  T. Gamblin,et al.  Importance of Histologic Subtype in the Staging of Appendiceal Tumors , 2012, Annals of Surgical Oncology.

[15]  F. Sessa,et al.  Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update , 2012, Cancers.

[16]  T. Gress,et al.  ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas , 2011, Neuroendocrinology.

[17]  A. Rashid,et al.  Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors. , 2011, Human pathology.

[18]  N. Harpaz,et al.  Goblet cell carcinoids at extraappendiceal locations of gastrointestinal tract: An underrecognized diagnostic pitfall , 2011, Journal of surgical oncology.

[19]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[20]  L. Sobin,et al.  Pathologic Classification and Clinical Behavior of the Spectrum of Goblet Cell Carcinoid Tumors of the Appendix , 2008, The American journal of surgical pathology.

[21]  T. Eimoto,et al.  Chromogranin A expression correlates with tumour cell type and prognosis in signet ring cell carcinoma of the stomach , 2008, Histopathology.

[22]  N. Hanna,et al.  Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity , 2007, Diagnostic pathology.

[23]  T. Eimoto,et al.  Composite glandular-endocrine cell carcinoma of the stomach. Report of two cases with goblet cell carcinoid component. , 2005, Pathology, research and practice.

[24]  J. Reis-Filho,et al.  Amphicrine gastric carcinoma. , 2001, Archives of pathology & laboratory medicine.

[25]  H. Rotterdam,et al.  Mixed (composite) glandular-endocrine cell carcinoma of the stomach. Report of a case and review of literature. , 1991, The American journal of surgical pathology.

[26]  F. Lee,et al.  Gastrointestinal pathology. An Atlas and Text , 1990 .

[27]  G. Chejfec,et al.  Amphicrine cells, dysplasias, and neoplasias , 1985, Cancer.

[28]  H. Blum,et al.  In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components , 2017, Modern Pathology.

[29]  M. Deacu,et al.  Morphological and immunohistochemical characteristics of a gastric amphicrine tumor: differential diagnosis considerations. , 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[30]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[31]  F. Bosman,et al.  Comprar WHO Classification of Tumours of the Digestive System | F. Bosman | 9789283224327 | WHO World Health Organization , 2010 .

[32]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[33]  L. Mándoky.  Amphicrine Tumor , 1999, Pathology & Oncology Research.

[34]  K. Lewin.  Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. , 1987, The American journal of surgical pathology.

[35]  O. Beahrs.  The American Joint Committee on Cancer. , 1984, Bulletin of the American College of Surgeons.

[36]  M. Ratzenhofer.  [Hyperplasias and tumours of the disseminated endocrine (paracrine) helle zellen Feyrter's of the gut with special regard of amphicrine cell proliferations (author's transl)]. , 1977, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[37]  F. Feyrter.  Über diffuse endokrine epitheliale organe , 1938 .